Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient’s Clinical Outcome in Triple-Negative Breast Cancer

Galectin-9 (Gal-9) is an immune checkpoint protein that facilitates T cell exhaustion and modulates the tumor-associated microenvironment, and could be a potential target for immune checkpoint inhibition. This study was conducted to assess Gal-9 expression in triple-negative breast cancer (TNBC) and...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Mi-Ha Ju, Kyung-Do Byun, Eun-Hwa Park, Jin-Hwa Lee, Song-Hee Han
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	Galectin-9 triple-negative breast cancer tumor-infiltrating lymphocyte PD-L1
Online Access:	https://www.mdpi.com/2227-9059/9/10/1383